One Hundred Patients Aged 65 and Older Who Underwent Emergency General Surgical InterventionsNCT06943924
A Comparative Study of CCI, EmSFI, and FTRST Scoring Systems
An observational study of One Hundred Patients Aged 65 and Older Who Underwent Emergency General Surgical Interventions and Clinical Utility of These Scoring Systems, run by Dr. Lutfi Kirdar Kartal Training and Research Hospital at 1 site in Turkey (Türkiye).
Trial summary
Frailty assessment tools and comorbidity indices play a crucial role, particularly in predicting outcomes for elderly patients undergoing emergency surgery. The Emergency Surgery Frailty Index (EmSFI), Charlson Comorbidity Index (CCI), and the Flemish version of the Triage Risk Screening Tool (fTRST) are considered… Read more about this study
- Who is it for?
- Ages 65 years and older
- Conditions the study is for
- One Hundred Patients Aged 65 and Older Who Underwent Emergency General Surgical Interventions, Clinical Utility of These Scoring Systems, Gastrointestinal Neoplasms
- What is being tested?
- Frailty assessment
- Type of treatment
- Surgery or procedure
- How many people
- 100 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 14 Mar 2023to 23 Oct 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- No healthy volunteers
- Older adult
Study population: Patients aged 65 years and older who underwent emergency abdominal surgery .
Who may be able to join
None listed.
Who cannot join
- Multiple hospitalizations for the same pathology,
- Initial admission at another facility,
- History of emergency abdominal surgery before the study period,
- Terminal-stage cancer
- Emergency reoperations following elective surgery,
- Surgery while in the intensive care unit.
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Dr Lutfi Kirdar City Hospital
Istanbul, Istanbul, 34870
About this study
Official title: COMPARISON OF CCI, EmSFI AND fTRST SCORING SYSTEMS IN PREDICTION OF MORTALITY IN EMERGENCY GENERAL SURGERY CASES OVER 65 YEARS OF AGE
Frailty assessment tools and comorbidity indices play a crucial role, particularly in predicting outcomes for elderly patients undergoing emergency surgery. The Emergency Surgery Frailty Index (EmSFI), Charlson Comorbidity Index (CCI), and the Flemish version of the Triage Risk Screening Tool (fTRST) are considered valuable tools that help understand patients perioperative risk profiles. This study aims to investigate the accuracy and clinical utility of these scoring systems in predicting mortality in individuals aged 65 and older undergoing emergency surgery
- Conditions
- One Hundred Patients Aged 65 and Older Who Underwent Emergency General Surgical Interventions, Clinical Utility of These Scoring Systems, Gastrointestinal Neoplasms, Appendicitis Acute, Emergency Surgery Patients
- Being tested
- Frailty assessment
- Keywords
- Emergency surgery, Frailty assessment, Mortality prediction
- Medical subject headings
- Gastrointestinal Neoplasms, Appendicitis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Frailty assessmentProcedure or surgery
This study aims to investigate the accuracy and clinical utility of these scoring systems in predicting mortality in individuals aged 65 and older undergoing emergency surgery.
What is being measured
The primary outcome is the main question the study is designed to answer.
Predicting 30-Day Mortality in Elderly Emergency Surgery Patients: A Comparative Study of CCI, EmSFI, and fTRST Scoring Systems
This study aims to investigate the accuracy and clinical utility of these scoring systems in predicting mortality in individuals aged 65 and older undergoing emergency surgery.
Measured: From enrollment to the postoperative at 1 month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Apr 2025
- Study start14 Mar 2023
- Primary completion31 Aug 2023
- Study completion23 Oct 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for One Hundred Patients Aged 65 and Older Who Underwent Emergency General Surgical InterventionsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 100 participants (actual)
Sponsor and investigators
- Lead sponsor
- Dr. Lutfi Kirdar Kartal Training and Research Hospital
- Sponsor type
- Other government
- Responsible party
- Principal investigator, GUHER TUNA DELIKANLI, Dr. Lutfi Kirdar Kartal Training and Research Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06943924
- Sponsor's protocol ID
- GDELIKANLI
- Other IDs
- 010.99/16
- Status last verified
- Jul 2025
- First submitted
- 17 Apr 2025
- Last updated
- 16 Jul 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 16 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- COMPARISON OF CCI, EmSFI AND fTRST SCORING SYSTEMS IN PREDICTION OF MORTALITY IN EMERGENCY GENERAL SURGERY CASES OVER 65 YEARS OF AGE
- ClinicalTrials.gov ID
- NCT06943924
- Acronym / sponsor ID
- GDELIKANLI
- Conditions
- One Hundred Patients Aged 65 and Older Who Underwent Emergency General Surgical Interventions, Clinical Utility of These Scoring Systems, Gastrointestinal Neoplasms, Appendicitis Acute, Emergency Surgery Patients
- Keywords
- Emergency surgery, Frailty assessment, Mortality prediction
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 100 participants (actual)
- Lead sponsor
- Dr. Lutfi Kirdar Kartal Training and Research HospitalOther government
- Study start
- 14 Mar 2023 (actual)
- Primary completion
- 31 Aug 2023 (actual)
- Study completion
- 23 Oct 2024 (actual)
- First posted
- 25 Apr 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Frailty assessment tools and comorbidity indices play a crucial role, particularly in predicting outcomes for elderly patients undergoing emergency surgery. The Emergency Surgery Frailty Index (EmSFI), Charlson Comorbidity Index (CCI), and the Flemish version of the Triage Risk Screening Tool (fTRST) are considered valuable tools that help understand patients perioperative risk profiles. This study aims to investigate the accuracy and clinical utility of these scoring systems in predicting mortality in individuals aged 65 and older undergoing emergency surgery
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Older adult
- Study population
- Patients aged 65 years and older who underwent emergency abdominal surgery .
Key inclusion criteria (0 listed)
Key exclusion criteria (6 listed)
- Multiple hospitalizations for the same pathology,
- Initial admission at another facility,
- History of emergency abdominal surgery before the study period,
- Terminal-stage cancer
- Emergency reoperations following elective surgery,
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Frailty assessmentThis study aims to investigate the accuracy and clinical utility of these scoring systems in predicting mortality in individuals aged 65 and older undergoing emergency surgery. | Procedure or surgery | – |
Primary outcome
Predicting 30-Day Mortality in Elderly Emergency Surgery Patients: A Comparative Study of CCI, EmSFI, and fTRST Scoring Systems
Time frame: From enrollment to the postoperative at 1 month
This study aims to investigate the accuracy and clinical utility of these scoring systems in predicting mortality in individuals aged 65 and older undergoing emergency surgery.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Jul 2025.
- Individual participant dataSharing planned: Undecided
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of One Hundred Patients Aged 65 and Older Who Underwent Emergency General Surgical Interventions and Clinical Utility of These Scoring Systems, run by Dr. Lutfi Kirdar Kartal Training and Research Hospital at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 0 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 16 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Predicting 30-Day Mortality in Elderly Emergency Surgery Patients: A Comparative Study of CCI, EmSFI, and fTRST Scoring Systems (time frame: From enrollment to the postoperative at 1 month). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jul 2025.